Dabigatran May Pose Excess Risk in Patients With Mechanical Valves
Patients with mechanical heart valves may be the last group considered for transition from warfarin to a novel anticoagulant; for now, at least, not to dabigatran.
Source: Consultant Live - Category: Primary Care Source Type: news
More News: Cardiology | Coumadin | Heart | Heart Valve Disease | Heart Valves | Pradaxa | Primary Care | Warfarin